Suchergebnisse - "De Zan, Erica"

PubPharm (6)

1

The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation

enthalten in: The Journal of biological chemistry | 2022

von Kulicke, C. | De Zan, E. | Hein, Z. | +10

2

The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Schwenzer, H. | De Zan, E. | Elshani, M. | +16

CommentOn: Clin Cancer Res. 2021 Dec 1;27(23):6279. - PMID 34853073

3

Quantitative genetic screening reveals a Ragulator-FLCN feedback loop that regulates the mTORC1 pathway

enthalten in: Science signaling | 2020

von De Zan, E. | van Stiphout, R. | Gapp, B. | +3

4

Dual Role For A MEK Inhibitor As A Modulator Of Inflammation And Host Defense Mechanisms With Potential Therapeutic Application In COPD

enthalten in: International journal of chronic obstructive pulmonary disease | 2019

von Kurian, N. | Cohen, T. | Öberg, L. | +9

5

Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles

enthalten in: Biomaterials | 2014

von Heukers, R. | Altintas, I. | Raghoenath, S. | +8

6

Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles

enthalten in: Biomaterials | 2014

von Heukers, R. | Altintas, I. | Raghoenath, S. | +8

1
[1]